These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15196371)

  • 1. [Antitumor immune responses induced by gene transfer of 4-1BBL into hepatocellular carcinoma Hepa1-6 in vitro].
    Liu CL; Dou KF; Zang XX; Zhu BF; Chen SM
    Zhonghua Wai Ke Za Zhi; 2004 May; 42(9):554-8. PubMed ID: 15196371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cloning, expression and antitumor effect of mouse costimulatory molecule 4-1BBL].
    Liu CL; Dou KF; Zhu BF; Zang XX; Chai YB; Du KJ; Chen SM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jan; 20(1):118-22. PubMed ID: 15182637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor immunity elicited by 4-1BBL gene transfected Hepa1-6 in vivo].
    Li X; Li X; Huang J; Wei L; Chen L; Wu M; Guo Y
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):409-12. PubMed ID: 12502438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostate cancer cell vaccine transfected with 4-1BBL induces anti-tumor immunity in vitro].
    Kuang YL; Weng XD; Liu XH; Chen ZY; Zhu HC; Jiang BT
    Zhonghua Nan Ke Xue; 2010 Sep; 16(9):773-7. PubMed ID: 21171257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumor.
    Dan Q; Sanchez R; Delgado C; Wepsic HT; Morgan K; Chen Y; Jeffes EW; Lowell CA; Morgan TR; Jadus MR
    Mol Ther; 2001 Nov; 4(5):427-37. PubMed ID: 11708879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological killing effect of recombicant adenovirus vector rAD-mTERT-m4-1BBL on mouse hepatoma cell line Hepa1-6 cells co-cultured with T lymphocytes].
    Xiao ZS; Ma SY; Gong WD; Yao HH; DU P; Xing YQ; Wu HR
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):894-8. PubMed ID: 20193326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
    Xu DP; Sauter BV; Huang TG; Meseck M; Woo SL; Chen SH
    Gene Ther; 2005 Oct; 12(20):1526-33. PubMed ID: 15973445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses.
    Kuang Y; Weng X; Liu X; Zhu H; Chen Z; Jiang B; Chen H
    Cancer Lett; 2010 Jul; 293(2):254-62. PubMed ID: 20149524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine.
    Guinn BA; DeBenedette MA; Watts TH; Berinstein NL
    J Immunol; 1999 Apr; 162(8):5003-10. PubMed ID: 10202049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T cell immunity against the non-immunogenic, murine, hepatocellular carcinoma Hepa1-6 is directed towards the novel alternative form of macrophage colony stimulating factor.
    Ge L; Zhang JG; Samathanam CA; Delgado C; Tarbiyat-Boldaji M; Dan Q; Hoa N; Nguyen TV; Alipanah R; Pham JT; Sanchez R; Wepsic HT; Morgan TR; Jadus MR
    Cell Immunol; 2009; 259(2):117-27. PubMed ID: 19615673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors.
    Guinn BA; Bertram EM; DeBenedette MA; Berinstein NL; Watts TH
    Cell Immunol; 2001 May; 210(1):56-65. PubMed ID: 11485353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-1BB (CD137) ligand enhanced anti-tumor immune response against mouse forestomach carcinoma in vivo.
    Li Q; Ai J; Song Z; Liu J; Shan B
    Cell Mol Immunol; 2008 Oct; 5(5):379-84. PubMed ID: 18954562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells.
    Yurkovetsky ZR; Shurin GV; Barry DA; Schuh AC; Shurin MR; Robbins PD
    J Gene Med; 2006 Feb; 8(2):129-37. PubMed ID: 16288496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12.
    Tamaki S; Homma S; Enomoto Y; Komita H; Zeniya M; Ohno T; Toda G
    Clin Immunol; 2005 Dec; 117(3):280-93. PubMed ID: 16246626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic antitumor response to cervical cancer in mice immunized with U14 vaccines transfected with costimulatory B7 gene.
    Tao G; Hu J; Zou H; Lin Q; Liu F; Wu Y; Sun Q
    Chin Med J (Engl); 2001 Jun; 114(6):623-7. PubMed ID: 11780440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma.
    Peng B; Liang L; Chen Z; He Q; Kuang M; Zhou F; Lu M; Huang J
    Hepatogastroenterology; 2006; 53(69):409-14. PubMed ID: 16795983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction of eukaryotic expression vector of mouse alpha-fetoprotein cDNA and its expression in dendritic cells and in vitro antitumor effect on hepatoma].
    Zeng B; Lu FG; Liu XW; Yang DY; Fang WY; Wang J; Liao AJ; Shi W
    Ai Zheng; 2005 Nov; 24(11):1332-7. PubMed ID: 16552958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of PCI-neo mammalian expression vector system containing murine 4-1BBL gene and its stable expression in hepatocellular carcinoma cell line].
    Li GQ; Wang XH; Yin J; Yu Y
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):328-31. PubMed ID: 12921558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The in vivo antitumor activity of murine liver tumor vaccine expressing MIP-1alpha].
    Yang Q; Yang G; Wei L; Jia F; Wang W; Wu M; Guo Y
    Zhonghua Wai Ke Za Zhi; 2002 Oct; 40(10):789-91. PubMed ID: 12487888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.